XML 31 R24.htm IDEA: XBRL DOCUMENT

Earnings per Share

3 Months Ended

Mar. 31, 2024

15. EARNINGS PER SHARE

We compute basic earnings per share by dividing net income attributable to Core Laboratories Inc. by the number of weighted average common shares outstanding during the period. Diluted earnings per share includes the incremental effect of contingently issuable shares from performance and restricted stock awards, as determined using the treasury stock method. The Redomestication Transaction had no effect on earnings per share for the periods presented.

The following table summarizes the calculation of weighted average shares of common stock outstanding used in the computation of basic and diluted earnings per share (in thousands):


	Three Months Ended
	March 31,
	2024		2023
Weighted average common shares outstanding - basic		46,859		46,634
Effect of dilutive securities:
Restricted shares		55		105
Performance shares		789		742
Weighted average common shares outstanding - diluted		47,703		47,481